PharmaBlock has released its 2021 Semi-Annual Report, highlighting the key positive results we achieved with our partners in 2021 H1. We have seen remarkable growth in both CDMO and building blocks business segments, as well as notable improvements in technological innovations and capacity expansion that lie ahead. 

View an overview of our 2021 Semi-Annual Report here.